379 related articles for article (PubMed ID: 31889307)
1. Structural neural markers of response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder.
Pagliaccio D; Cha J; He X; Cyr M; Yanes-Lukin P; Goldberg P; Fontaine M; Rynn MA; Marsh R
J Child Psychol Psychiatry; 2020 Dec; 61(12):1299-1308. PubMed ID: 31889307
[TBL] [Abstract][Full Text] [Related]
2. MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
O'Neill J; Piacentini JC; Chang S; Levitt JG; Rozenman M; Bergman L; Salamon N; Alger JR; McCracken JT
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):161-8. PubMed ID: 21983143
[TBL] [Abstract][Full Text] [Related]
3. Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial.
Russman Block S; Norman LJ; Zhang X; Mannella KA; Yang H; Angstadt M; Abelson JL; Himle JA; Taylor SF; Fitzgerald KD
Am J Psychiatry; 2023 Jan; 180(1):89-99. PubMed ID: 36475374
[TBL] [Abstract][Full Text] [Related]
4. The effects of cognitive behavioral therapy on the whole brain structural connectome in unmedicated patients with obsessive-compulsive disorder.
Cao R; Yang X; Luo J; Wang P; Meng F; Xia M; He Y; Zhao T; Li Z
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110037. PubMed ID: 32682876
[TBL] [Abstract][Full Text] [Related]
5. Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
Cyr M; Pagliaccio D; Yanes-Lukin P; Fontaine M; Rynn MA; Marsh R
Neuropsychopharmacology; 2020 Jun; 45(7):1232-1240. PubMed ID: 31952071
[TBL] [Abstract][Full Text] [Related]
6. Right Prefrontal Cortical Thickness Is Associated With Response to Cognitive-Behavioral Therapy in Children With Obsessive-Compulsive Disorder.
Bertolín S; Alonso P; Martínez-Zalacaín I; Menchón JM; Jimenez-Murcia S; Baker JT; Bargalló N; Batistuzzo MC; Boedhoe PSW; Brennan BP; Feusner JD; Fitzgerald KD; Fontaine M; Hansen B; Hirano Y; Hoexter MQ; Huyser C; Jahanshad N; Jaspers-Fayer F; Kuno M; Kvale G; Lazaro L; Machado-Sousa M; Marsh R; Morgado P; Nakagawa A; Norman L; Nurmi EL; O'Neill J; Ortiz AE; Perriello C; Piacentini J; Picó-Pérez M; Shavitt RG; Shimizu E; Simpson HB; Stewart SE; Thomopoulos SI; Thorsen AL; Walitza S; Wolters LH; ; Thompson PM; van den Heuvel OA; Stein DJ; Soriano-Mas C
J Am Acad Child Adolesc Psychiatry; 2023 Apr; 62(4):403-414. PubMed ID: 36526161
[TBL] [Abstract][Full Text] [Related]
7. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
O'Neill J; Piacentini J; Chang S; Ly R; Lai TM; Armstrong CC; Bergman L; Rozenman M; Peris T; Vreeland A; Mudgway R; Levitt JG; Salamon N; Posse S; Hellemann GS; Alger JR; McCracken JT; Nurmi EL
Neuropsychopharmacology; 2017 Nov; 42(12):2414-2422. PubMed ID: 28409563
[TBL] [Abstract][Full Text] [Related]
8. One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.
Højgaard DRMA; Hybel KA; Ivarsson T; Skarphedinsson G; Becker Nissen J; Weidle B; Melin K; Torp NC; Valderhaug R; Dahl K; Mortensen EL; Compton S; Jensen S; Lenhard F; Thomsen PH
J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):940-947.e1. PubMed ID: 29096776
[TBL] [Abstract][Full Text] [Related]
9. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
10. Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
Skarphedinsson G; De Nadai AS; Storch EA; Lewin AB; Ivarsson T
Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):47-55. PubMed ID: 27209422
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
12. Resting-state functional connectivity of amygdala subregions predicts treatment outcome for cognitive behavioral therapy in obsessive-compulsive disorder at a 4-month follow-up.
Li W; Xie M; Chen H; Zhang X; Zhang H; Xu Z; Song S; Wang Z; Jiang W; Jiang Y; Liu N; Zhang N
Psychiatry Res; 2024 May; 335():115876. PubMed ID: 38564923
[TBL] [Abstract][Full Text] [Related]
13. Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
Lenhard F; Andersson E; Mataix-Cols D; Rück C; Vigerland S; Högström J; Hillborg M; Brander G; Ljungström M; Ljótsson B; Serlachius E
J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):10-19.e2. PubMed ID: 27993223
[TBL] [Abstract][Full Text] [Related]
14. Network-based functional connectivity predicts response to exposure therapy in unmedicated adults with obsessive-compulsive disorder.
Shi TC; Pagliaccio D; Cyr M; Simpson HB; Marsh R
Neuropsychopharmacology; 2021 Apr; 46(5):1035-1044. PubMed ID: 33446895
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
16. Resting-state functional connectivity of the amygdala subregions in unmedicated patients with obsessive-compulsive disorder before and after cognitive behavioural therapy.
Gao J; Yang X; Chen X; Liu R; Wang P; Meng F; Li Z; Zhou Y
J Psychiatry Neurosci; 2021; 46(6):E628-E638. PubMed ID: 34785511
[TBL] [Abstract][Full Text] [Related]
17. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
[TBL] [Abstract][Full Text] [Related]
18. Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.
Pagliaccio D; Middleton R; Hezel D; Steinman S; Snorrason I; Gershkovich M; Campeas R; Pinto A; Van Meter P; Simpson HB; Marsh R
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20346-20353. PubMed ID: 31548396
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study.
Merlo LJ; Storch EA; Lehmkuhl HD; Jacob ML; Murphy TK; Goodman WK; Geffken GR
Cogn Behav Ther; 2010; 39(1):24-7. PubMed ID: 19675960
[TBL] [Abstract][Full Text] [Related]
20. Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial.
Freeman J; Sapyta J; Garcia A; Compton S; Khanna M; Flessner C; FitzGerald D; Mauro C; Dingfelder R; Benito K; Harrison J; Curry J; Foa E; March J; Moore P; Franklin M
JAMA Psychiatry; 2014 Jun; 71(6):689-98. PubMed ID: 24759852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
